BR100 Decreased By (-0.95%)
BR30 Decreased By (-1.6%)
KSE100 Decreased By (-0.75%)
KSE30 Decreased By (-0.72%)
AGHA 6.69 Increased By ▲ 0.01 (0.15%)
BECO 4.39 Increased By ▲ 0.02 (0.46%)
BML 56.00 Decreased By ▼ -1.32 (-2.3%)
BOP 30.12 Decreased By ▼ -0.23 (-0.76%)
CNERGY 12.92 Decreased By ▼ -0.20 (-1.52%)
CSIL 5.31 Decreased By ▼ -0.10 (-1.85%)
FCCL 51.49 Decreased By ▼ -1.30 (-2.46%)
FFL 14.47 Decreased By ▼ -0.25 (-1.7%)
FNEL 1.21 Increased By ▲ 0.09 (8.04%)
KEL 6.05 Decreased By ▼ -0.04 (-0.66%)
KOSM 5.86 Increased By ▲ 0.13 (2.27%)
LOTCHEM 26.20 Decreased By ▼ -0.26 (-0.98%)
MLCF 91.25 Decreased By ▼ -1.91 (-2.05%)
NBP 164.26 Decreased By ▼ -0.40 (-0.24%)
NCPL 53.21 Decreased By ▼ -2.45 (-4.4%)
NPL 59.40 Decreased By ▼ -1.76 (-2.88%)
OGDC 312.80 Decreased By ▼ -3.93 (-1.24%)
PACE 9.72 Decreased By ▼ -0.15 (-1.52%)
PAEL 35.28 Decreased By ▼ -0.35 (-0.98%)
PIBTL 14.72 Increased By ▲ 0.04 (0.27%)
PPL 221.00 Decreased By ▼ -5.91 (-2.6%)
PRL 90.90 Decreased By ▼ -2.12 (-2.28%)
PTC 59.00 Decreased By ▼ -1.26 (-2.09%)
SSGC 23.30 Decreased By ▼ -0.51 (-2.14%)
TBL 8.71 Decreased By ▼ -0.04 (-0.46%)
TELE 7.57 Decreased By ▼ -0.23 (-2.95%)
TPL 22.08 Decreased By ▼ -0.27 (-1.21%)
TPLP 12.55 Decreased By ▼ -0.42 (-3.24%)
TREET 21.77 Decreased By ▼ -0.39 (-1.76%)
TRG 55.69 Decreased By ▼ -0.87 (-1.54%)

KARACHI: In line with our vision to be trusted global healthcare partner - CCL in Vietnam has ventured into an exclusive marketing and distribution agreement, leading to a joint venture, with AJRP Malaysia – a Global Healthcare Conglomerate”, shares Atif Siddiqui, President CCL Life Sciences.

The contract was signed on 1st April 2021 by Jaudat Amin – Business Head CCL South East Asia and D.S. Jamil Bidin – CEO AJRP Malaysia. CCL envisions to meet everyday health, nutrition, home and personal care needs of a billion people in developing countries – making them happy, feel good and get more out of life. To be able to do so, we aspire to be trusted global healthcare partners, offering unique solutions for all stages of life.

CCL has a legacy of over 50 years, with a global footprint in 22 countries and counting. We specialize in pharmaceuticals, consumer healthcare, food and nutrition and digital health products. Our strategic partners have a proven track record of over 70 years, operating in healthcare, life sciences, food and beverage, oil and gas and the automotive sector. Together, we aim to bring quality life products to our consumers, and contribute towards strengthening the Global Consumer Healthcare portfolio in the region.—PR

Copyright Business Recorder, 2021

Comments

Comments are closed for this article.